GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
NASDAQ:RXDX
Delisted

Prometheus Biosciences Inc Stock Price (Quote)

NASDAQ Stock Exchange > Healthcare > Biotechnology
Open Broker Account
$199.92
+0 (+0%)
At Close: Sep 14, 2023
Forecast Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $199.92 $199.92 Thursday, 14th Sep 2023 RXDX stock ended at $199.92. During the day the stock fluctuated 0% from a day low at $199.92 to a day high of $199.92.
90 days $199.92 $199.92
52 weeks $30.75 $199.96

Historical Prometheus Biosciences Inc prices

Date Open High Low Close Volume
Sep 14, 2023 $199.92 $199.92 $199.92 $199.92 0
Sep 13, 2023 $199.92 $199.92 $199.92 $199.92 0
Sep 12, 2023 $199.92 $199.92 $199.92 $199.92 0
Sep 11, 2023 $199.92 $199.92 $199.92 $199.92 0
Sep 08, 2023 $199.92 $199.92 $199.92 $199.92 0
Sep 07, 2023 $199.92 $199.92 $199.92 $199.92 0
Sep 06, 2023 $199.92 $199.92 $199.92 $199.92 0
Sep 05, 2023 $199.92 $199.92 $199.92 $199.92 0
Sep 01, 2023 $199.92 $199.92 $199.92 $199.92 0
Aug 31, 2023 $199.92 $199.92 $199.92 $199.92 0
Aug 30, 2023 $199.92 $199.92 $199.92 $199.92 0
Aug 29, 2023 $199.92 $199.92 $199.92 $199.92 0
Aug 28, 2023 $199.92 $199.92 $199.92 $199.92 0
Aug 25, 2023 $199.92 $199.92 $199.92 $199.92 0
Aug 24, 2023 $199.92 $199.92 $199.92 $199.92 0
Aug 23, 2023 $199.92 $199.92 $199.92 $199.92 0
Aug 22, 2023 $199.92 $199.92 $199.92 $199.92 0
Aug 21, 2023 $199.92 $199.92 $199.92 $199.92 0
Aug 18, 2023 $199.92 $199.92 $199.92 $199.92 0
Aug 17, 2023 $199.92 $199.92 $199.92 $199.92 0
Aug 16, 2023 $199.92 $199.92 $199.92 $199.92 0
Aug 15, 2023 $199.92 $199.92 $199.92 $199.92 0
Aug 14, 2023 $199.92 $199.92 $199.92 $199.92 0
Aug 11, 2023 $199.92 $199.92 $199.92 $199.92 0
Aug 10, 2023 $199.92 $199.92 $199.92 $199.92 0
Click to get the best stock tips daily for free!

About Prometheus Biosciences Inc

Prometheus Biosciences Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial for the treatment of ulcerative colitis and Crohn's disease, as well as systemic sclerosis-associated ... RXDX Profile 

^ false

Golden Star

Ticker Date Change Price
FTSL Apr 18 0.130% $46.22
LNG Apr 17 2.33% $156.81
FCN Apr 16 1.98% $207.62
ELV Apr 16 4.98% $506.97
AKR Apr 05 5.38% $16.53
ITCI Apr 05 8.91% $68.44
SARK Mar 28 17.19% $26.88
ARCC Mar 25 2.68% $20.12
CCK Mar 20 2.77% $77.29
STT Mar 19 2.60% $72.62
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT